Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic. - Wikidata - awgldk - TriplyDB

Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic.

Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic.

http://www.wikidata.org/entity/Q33286372

about

Feasibility evaluation of an online tool to guide decisions for BRCA1/2 mutation carriers.Contralateral prophylactic mastectomy and survival: report from the National Cancer Data Base, 1998-2002.Standard psychological consultations and follow up for women at increased risk of hereditary breast cancer considering prophylactic mastectomy Genetic risk assessments in individuals at high risk for inherited breast cancer in the breast oncology care setting.Risk-reducing strategies for women carrying BRCA1/2 mutations with a focus on prophylactic surgery.Hereditary breast cancer: clinical, pathological and molecular characteristics.Predictors that influence contralateral prophylactic mastectomy election among women with ductal carcinoma in situ who were evaluated for BRCA genetic testing.The Angelina Jolie Effect in Jewish Law: Prophylactic Mastectomy and Oophorectomy in BRCA Carriers The impact of an interventional counselling procedure in families with a BRCA1/2 gene mutation: efficacy and safety Genetic counselling and testing for inherited gene mutations in newly diagnosed patients with breast cancer: a review of the existing literature and a proposed research agenda.Identification, Evaluation, and Treatment of Patients with Hereditary Cancer Risk within the United States.New insights into the prevention and treatment of familial breast cancer.Managing the breast in patients who test positive for hereditary breast cancer.Determinants of optimal mastectomy skin flap thickness.A systematic review of men's experiences of their partner's mastectomy: coping with altered bodies.Nipple-sparing mastectomy in BRCA1/2 mutation carriers: an interim analysis and review of the literature.Genetic testing today.Surgical Decision Making in the BRCA-Positive Population: Institutional Experience and Comparison with Recent Literature.Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy.Impact that Timing of Genetic Mutation Diagnosis has on Surgical Decision Making and Outcome for BRCA1/BRCA2 Mutation Carriers with Breast Cancer.Breast cancer after bilateral risk-reducing mastectomy.Occult Histopathology and Its Predictors in Contralateral and Bilateral Prophylactic Mastectomies.More answers about prophylactic mastectomy.Residual breast tissue after mastectomy: how often and where is it located?The frequency and outcome of breast cancer risk-reducing surgery in Finnish BRCA1 and BRCA2 mutation carriers.Network-pharmacology-based validation of TAMS/CXCL-1 as key mediator of XIAOPI formula preventing breast cancer development and metastasis.Missed therapeutic and prevention opportunities in women with BRCA-mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature.The psychological impact of breast and ovarian cancer preventive options in BRCA1 and BRCA2 mutation carriers.Can chimerism explain breast/ovarian cancers in BRCA non-carriers from BRCA-positive families?Pathology of hereditary breast cancer.Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer.Body image issues after bilateral prophylactic mastectomy with breast reconstruction in healthy women at risk for hereditary breast cancer Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening†

P2860

Q27316521-DCBFCCD9-44E2-4EAE-8863-4F8BC3B7241C Q30692732-063B1A63-E1A5-44C1-87FB-34252C832CF0 Q33425460-2E6BC47E-2C17-4E92-8BDE-18B394895915 Q33564013-7A4E39C4-4765-4146-BFD4-8D7CA56A240E Q33723561-021082B1-BCD3-4831-B8BB-BBABB3B2535B Q34425230-AC4DC12F-0F97-4C06-B6DE-214A103B9DC4 Q34471501-2C1B9CD7-17FC-47C5-AA4B-F51DFB3ECED8 Q36218446-8C0BC362-0C87-46C3-86BB-5F238D3313CD Q36717832-9B30AA89-6FDD-46F5-B3C2-A5537623C7DE Q37131303-2E43FB36-E4A4-40EB-8146-6925B070FE9C Q37450153-53035A0D-C81E-49C0-BFBE-A0E7FBAA5F87 Q37845305-18847A33-76A9-4F3E-8B8C-87EC69383FB6 Q37991240-1693B575-9C97-4E00-B357-8FBD08D35338 Q38199008-BF5B6BBF-9D2A-4E27-9E94-6577A9C8B0AA Q38209706-C94D8E4F-2870-43A5-BA09-5E41D36BE8EC Q38229437-B23D906A-CAE0-4AC5-8266-E4ACA9ED46B7 Q38230196-B057B92E-3B3F-4E4D-B456-86AEA47F55DF Q38676694-28B6E165-1C83-4083-AB00-3385DC6AF039 Q39033804-492E64C4-F6B7-4BE8-9412-D098C1420727 Q39659182-47ABF593-8591-4E73-8C37-628AF8EE1146 Q39797410-4E95363E-3AFB-45FA-8ED2-5376EE361B09 Q40312428-C335C98C-B7FD-44BA-940B-5FFFF2B18284 Q42718852-C6727C81-31CF-469D-BC14-B56C69C77872 Q45923040-7C0E6284-1ED0-4977-B922-D2BF92C84BA8 Q46301352-B65F5E57-98A9-4A78-A91D-B5F44C6DC4EF Q47098338-BE16A200-F181-4BF7-B5E2-78B808B16D3D Q48110433-31EFED72-144C-45E5-9C37-8554C4F1F935 Q48154043-EC02C372-9611-44B3-80EC-1B0940B555D2 Q52586080-B227E1F0-B3F7-48C4-8D0B-71E208FED878 Q55110010-8B7AE7F9-FCB0-430B-9B6F-F1558659B992 Q55437668-C2539AAA-9F77-4179-8893-2D09F239E7FC Q57947254-5FC8A182-4ED4-4E5D-920C-0A6DA45EFE2E Q59273721-F7E42E41-20E2-4BDB-B508-0FFA57CD1DA9

P2860

Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic.

http://www.wikidata.org/entity/Q33286372

description

2007 nî lūn-bûn

@nan

2007 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Prophylactic mastectomy in BRC ...... otterdam Family Cancer Clinic.

@ast

Prophylactic mastectomy in BRC ...... otterdam Family Cancer Clinic.

@en

Prophylactic mastectomy in BRC ...... otterdam Family Cancer Clinic.

@nl

type

label

Prophylactic mastectomy in BRC ...... otterdam Family Cancer Clinic.

@ast

Prophylactic mastectomy in BRC ...... otterdam Family Cancer Clinic.

@en

Prophylactic mastectomy in BRC ...... otterdam Family Cancer Clinic.

@nl

prefLabel

Prophylactic mastectomy in BRC ...... otterdam Family Cancer Clinic.

@ast

Prophylactic mastectomy in BRC ...... otterdam Family Cancer Clinic.

@en

Prophylactic mastectomy in BRC ...... otterdam Family Cancer Clinic.

@nl

P1433

Q33286372-C1DA8F6A-7D93-4759-8218-FE49EC6641FE

P1476

Q33286372-076A33CD-1CCD-42DB-B27C-1CBEF218AC36

P2093

Q33286372-0E09222B-C8C9-4A34-A2E1-3C218D75DE62

Q33286372-18FC6A7A-EA3A-4253-BE60-DD018DB0FB3B

Q33286372-3886F055-4EBB-49BB-A0D4-CD9A0E2ADB32

Q33286372-593E57B0-BB38-4C1B-B7BD-8BA7E01EB91E

Q33286372-7A2DE089-04E2-4753-8AFD-D24ED706104E

Q33286372-7DF46143-7B40-4486-8DA8-A89C43437D3B

Q33286372-953C4774-22C7-4A11-BC4A-D42943EBFAA4

Q33286372-BB5E1DBD-D357-4539-9EF7-05619C6E13E3

Q33286372-CC29476E-1D81-4F58-9875-4B1429FA0D5B

P2860

Q33286372-029008A5-B2E5-41DD-BBA6-27073CF81471

Q33286372-08CB2138-AA12-4ADC-AA17-4418DDE9AEE1

Q33286372-0D12A177-7030-416E-99A2-6B759CB2042F

Q33286372-0DC1C64A-C976-4662-B97C-972ACD4BF99C

Q33286372-16DC75B2-24A3-4DCC-8500-6BF6DF9939D4

Q33286372-17345713-BB2C-47BB-9873-C48BCDA2074A

Q33286372-18B53637-121A-4DAC-B7BD-E5C5B479D518

Q33286372-2962DE55-324D-44DE-94A1-6FF1F22173B9

Q33286372-3335B328-D490-4B66-8C89-FD9568B20D9C

Q33286372-420ADD01-3AE0-4847-AD71-2E29C3D584D0

P2888

Q33286372-0CFEE174-976F-4746-A20C-FA5186D1D3D2

P304

Q33286372-A64D1810-EBF2-4B02-BA09-DE8C84B5BCBF

P31

Q33286372-B4A8079E-7A79-4DC9-AAA9-52F685569AB7

P356

Q33286372-37433FDB-E663-4F13-AAD0-1C2E1BFD175F

P433

Q33286372-5C5C56B9-F589-444E-B6DA-2536FC488F49

P478

Q33286372-E9AFB7ED-8A17-440B-878A-544A2F5063EB

P50

Q33286372-DABFFD2C-77C0-491F-BDC9-B131E0783DC7

P577

Q33286372-2372DAE5-CC13-49ED-B540-02995B4A0877

P5875

Q33286372-827D9A5F-D46D-46A8-8593-C877550BCA13

P6179

Q33286372-CE9C8D54-81D2-4384-8D01-AC4585529F2B

P698

Q33286372-6585C3BF-4113-450A-86EA-D70BD978DD91

P932

Q33286372-E1D634D3-D6FC-4178-9F6A-44318E924A3D

P356

S10434-007-9449-X

P1433

Annals of Surgical Oncology

P1476

Prophylactic mastectomy in BRC ...... otterdam Family Cancer Clinic.

@en

P2093

Albert N van Geel

http://www.w3.org/2001/XMLSchema#string

Bernadette A M Heemskerk-Gerritsen

http://www.w3.org/2001/XMLSchema#string

Carina C M Bartels

http://www.w3.org/2001/XMLSchema#string

Cecile T M Brekelmans

http://www.w3.org/2001/XMLSchema#string

Hanne E J Meijers-Heijboer

http://www.w3.org/2001/XMLSchema#string

Jan G M Klijn

http://www.w3.org/2001/XMLSchema#string

Madeleine M A Tilanus-Linthorst

http://www.w3.org/2001/XMLSchema#string

Marian B E Menke-Pluymers

http://www.w3.org/2001/XMLSchema#string

Murly Tan

http://www.w3.org/2001/XMLSchema#string

P2860

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

An outcome study of breast reconstruction: presurgical identification of risk factors for complications.

Systematic review of management options for women with a hereditary predisposition to ovarian cancer.

Mastectomy by inverted drip incision and immediate reconstruction: data from 510 cases.

Survival in hereditary breast cancer associated with germline mutations of BRCA2.

Morbidity of immediate breast reconstruction (IBR) after mastectomy by a subpectorally placed silicone prosthesis: the adverse effect of radiotherapy.

Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer

Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families.

P2888

s10434-007-9449-x

P304

3335-3344

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-007-9449-X

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Caroline Seynaeve

P577

2007-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6294045

http://www.w3.org/2001/XMLSchema#string

P6179

1052936329

http://www.w3.org/2001/XMLSchema#string

P698

17541692

http://www.w3.org/2001/XMLSchema#string

P932

2077910

http://www.w3.org/2001/XMLSchema#string